JP4445658B2 - Cosmetics - Google Patents
Cosmetics Download PDFInfo
- Publication number
- JP4445658B2 JP4445658B2 JP2000312429A JP2000312429A JP4445658B2 JP 4445658 B2 JP4445658 B2 JP 4445658B2 JP 2000312429 A JP2000312429 A JP 2000312429A JP 2000312429 A JP2000312429 A JP 2000312429A JP 4445658 B2 JP4445658 B2 JP 4445658B2
- Authority
- JP
- Japan
- Prior art keywords
- extract
- acid
- skin
- genus
- production example
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000002537 cosmetic Substances 0.000 title claims description 18
- 239000000284 extract Substances 0.000 claims description 41
- 230000000694 effects Effects 0.000 claims description 12
- 241000196324 Embryophyta Species 0.000 claims description 11
- 230000002087 whitening effect Effects 0.000 claims description 10
- 244000180021 Pandanus odorus Species 0.000 claims description 3
- 239000000203 mixture Substances 0.000 claims description 3
- 235000012110 Pandanus odorus Nutrition 0.000 claims description 2
- -1 jojoba oil Substances 0.000 description 29
- 238000004519 manufacturing process Methods 0.000 description 24
- 239000000243 solution Substances 0.000 description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 15
- 208000012641 Pigmentation disease Diseases 0.000 description 15
- 238000012360 testing method Methods 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 230000019612 pigmentation Effects 0.000 description 12
- 239000000843 powder Substances 0.000 description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 11
- 235000014113 dietary fatty acids Nutrition 0.000 description 11
- 239000000194 fatty acid Substances 0.000 description 11
- 229930195729 fatty acid Natural products 0.000 description 11
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 10
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 9
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 9
- 239000006071 cream Substances 0.000 description 9
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 9
- 229960004705 kojic acid Drugs 0.000 description 9
- 239000008213 purified water Substances 0.000 description 9
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 8
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 8
- 239000003205 fragrance Substances 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- 239000004615 ingredient Substances 0.000 description 6
- 239000003921 oil Substances 0.000 description 6
- 235000019198 oils Nutrition 0.000 description 6
- 239000000419 plant extract Substances 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- 239000000523 sample Substances 0.000 description 6
- 206010015150 Erythema Diseases 0.000 description 5
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 5
- 241000233930 Pandanus Species 0.000 description 5
- 235000005308 Pandanus Nutrition 0.000 description 5
- 102000003425 Tyrosinase Human genes 0.000 description 5
- 108060008724 Tyrosinase Proteins 0.000 description 5
- 231100000321 erythema Toxicity 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 238000000605 extraction Methods 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- 229940058015 1,3-butylene glycol Drugs 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 241000238413 Octopus Species 0.000 description 4
- 208000025174 PANDAS Diseases 0.000 description 4
- 208000021155 Paediatric autoimmune neuropsychiatric disorders associated with streptococcal infection Diseases 0.000 description 4
- 240000004718 Panda Species 0.000 description 4
- 235000016496 Panda oleosa Nutrition 0.000 description 4
- 206010040880 Skin irritation Diseases 0.000 description 4
- 239000004480 active ingredient Substances 0.000 description 4
- 235000019437 butane-1,3-diol Nutrition 0.000 description 4
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 229940057995 liquid paraffin Drugs 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 4
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 4
- 229960002216 methylparaben Drugs 0.000 description 4
- 231100000475 skin irritation Toxicity 0.000 description 4
- 230000036556 skin irritation Effects 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 238000010998 test method Methods 0.000 description 4
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 229920001214 Polysorbate 60 Polymers 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 150000001298 alcohols Chemical class 0.000 description 3
- 239000003788 bath preparation Substances 0.000 description 3
- 239000007844 bleaching agent Substances 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 230000007794 irritation Effects 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- PGSADBUBUOPOJS-UHFFFAOYSA-N neutral red Chemical compound Cl.C1=C(C)C(N)=CC2=NC3=CC(N(C)C)=CC=C3N=C21 PGSADBUBUOPOJS-UHFFFAOYSA-N 0.000 description 3
- 235000013772 propylene glycol Nutrition 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- DGSZGZSCHSQXFV-UHFFFAOYSA-N 2,3-bis(2-ethylhexanoyloxy)propyl 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(OC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DGSZGZSCHSQXFV-UHFFFAOYSA-N 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 240000002390 Pandanus odoratissimus Species 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 125000005037 alkyl phenyl group Chemical group 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 229960000271 arbutin Drugs 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 2
- 244000309466 calf Species 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 230000003834 intracellular effect Effects 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- 239000010445 mica Substances 0.000 description 2
- 229910052618 mica group Inorganic materials 0.000 description 2
- 239000011259 mixed solution Substances 0.000 description 2
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 229930014626 natural product Natural products 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 230000036961 partial effect Effects 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- QELSKZZBTMNZEB-UHFFFAOYSA-N propylparaben Chemical compound CCCOC(=O)C1=CC=C(O)C=C1 QELSKZZBTMNZEB-UHFFFAOYSA-N 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000005846 sugar alcohols Polymers 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 150000003722 vitamin derivatives Chemical class 0.000 description 2
- HRBSSAKLPZCBPP-LICCNWEZSA-N (2r)-3,4-dihydroxy-2-[(1s)-2-hydroxy-1-[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyethyl]-2h-furan-5-one Chemical compound O([C@@H](CO)[C@@H]1C(=C(O)C(=O)O1)O)[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HRBSSAKLPZCBPP-LICCNWEZSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- 150000005207 1,3-dihydroxybenzenes Chemical class 0.000 description 1
- PZNPLUBHRSSFHT-RRHRGVEJSA-N 1-hexadecanoyl-2-octadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCCC(=O)O[C@@H](COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCCCCCCCCCC PZNPLUBHRSSFHT-RRHRGVEJSA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- ZXDDPOHVAMWLBH-UHFFFAOYSA-N 2,4-Dihydroxybenzophenone Chemical compound OC1=CC(O)=CC=C1C(=O)C1=CC=CC=C1 ZXDDPOHVAMWLBH-UHFFFAOYSA-N 0.000 description 1
- ATWGXJGRRXIETI-UHFFFAOYSA-N 2,5-diacetyloxybenzoic acid Chemical compound CC(=O)OC1=CC=C(OC(C)=O)C(C(O)=O)=C1 ATWGXJGRRXIETI-UHFFFAOYSA-N 0.000 description 1
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical class OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- JKRDADVRIYVCCY-UHFFFAOYSA-N 2-hydroxyoctanoic acid Chemical compound CCCCCCC(O)C(O)=O JKRDADVRIYVCCY-UHFFFAOYSA-N 0.000 description 1
- HWLBIEAKJSRKOD-UHFFFAOYSA-N 2-octadecanoyloxyacetic acid Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)=O HWLBIEAKJSRKOD-UHFFFAOYSA-N 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- NYARJMRXCRSQPJ-UHFFFAOYSA-N 4-(3-methylbutyl)benzene-1,3-diol Chemical compound CC(C)CCC1=CC=C(O)C=C1O NYARJMRXCRSQPJ-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- CSHZYWUPJWVTMQ-UHFFFAOYSA-N 4-n-Butylresorcinol Chemical compound CCCCC1=CC=C(O)C=C1O CSHZYWUPJWVTMQ-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 229920002126 Acrylic acid copolymer Polymers 0.000 description 1
- 240000007474 Aloe arborescens Species 0.000 description 1
- 235000004509 Aloe arborescens Nutrition 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 241001237961 Amanita rubescens Species 0.000 description 1
- 241000499945 Amaryllis Species 0.000 description 1
- DKPFZGUDAPQIHT-UHFFFAOYSA-N Butyl acetate Natural products CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- HHWGNVNKUZIUNK-UHFFFAOYSA-N C(=O)(O)[Na].N1C(CCC1)=O Chemical compound C(=O)(O)[Na].N1C(CCC1)=O HHWGNVNKUZIUNK-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- WJLVQTJZDCGNJN-UHFFFAOYSA-N Chlorhexidine hydrochloride Chemical compound Cl.Cl.C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 WJLVQTJZDCGNJN-UHFFFAOYSA-N 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 241001522723 Conoidea Species 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 239000004287 Dehydroacetic acid Substances 0.000 description 1
- MDNWOSOZYLHTCG-UHFFFAOYSA-N Dichlorophen Chemical compound OC1=CC=C(Cl)C=C1CC1=CC(Cl)=CC=C1O MDNWOSOZYLHTCG-UHFFFAOYSA-N 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- ILKBHIBYKSHTKQ-UHFFFAOYSA-N Diisopropylamine dichloroacetate Chemical compound OC(=O)C(Cl)Cl.CC(C)NC(C)C ILKBHIBYKSHTKQ-UHFFFAOYSA-N 0.000 description 1
- 239000006145 Eagle's minimal essential medium Substances 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 1
- 229920002079 Ellagic acid Polymers 0.000 description 1
- 206010014970 Ephelides Diseases 0.000 description 1
- 240000008620 Fagopyrum esculentum Species 0.000 description 1
- 235000009419 Fagopyrum esculentum Nutrition 0.000 description 1
- 241001071795 Gentiana Species 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- MLSJBGYKDYSOAE-DCWMUDTNSA-N L-Ascorbic acid-2-glucoside Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)=C1O MLSJBGYKDYSOAE-DCWMUDTNSA-N 0.000 description 1
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 1
- 239000002211 L-ascorbic acid Substances 0.000 description 1
- 235000000069 L-ascorbic acid Nutrition 0.000 description 1
- MIJPAVRNWPDMOR-ZAFYKAAXSA-N L-ascorbic acid 2-phosphate Chemical compound OC[C@H](O)[C@H]1OC(=O)C(OP(O)(O)=O)=C1O MIJPAVRNWPDMOR-ZAFYKAAXSA-N 0.000 description 1
- XDBMXUKHMOFBPJ-ZAFYKAAXSA-N L-ascorbic acid 2-sulfate Chemical compound OC[C@H](O)[C@H]1OC(=O)C(OS(O)(=O)=O)=C1O XDBMXUKHMOFBPJ-ZAFYKAAXSA-N 0.000 description 1
- 150000000996 L-ascorbic acids Chemical class 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- RJUFJBKOKNCXHH-UHFFFAOYSA-N Methyl propionate Chemical compound CCC(=O)OC RJUFJBKOKNCXHH-UHFFFAOYSA-N 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000005311 Pandanus odoratissimus Nutrition 0.000 description 1
- 240000000004 Parmentiera aculeata Species 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 240000008077 Ruellia tuberosa Species 0.000 description 1
- 244000288377 Saxifraga stolonifera Species 0.000 description 1
- 235000002953 Saxifraga stolonifera Nutrition 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- OFUHPGMOWVHNPN-QWZFGMNQSA-N [(2r)-2,5,7,8-tetramethyl-2-[(4r,8r)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl] (9z,12z)-octadeca-9,12-dienoate Chemical compound O1[C@](C)(CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CCC2=C(C)C(OC(=O)CCCCCCC\C=C/C\C=C/CCCCC)=C(C)C(C)=C21 OFUHPGMOWVHNPN-QWZFGMNQSA-N 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 125000002947 alkylene group Chemical group 0.000 description 1
- 229940061720 alpha hydroxy acid Drugs 0.000 description 1
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 229940093740 amino acid and derivative Drugs 0.000 description 1
- 229960002298 aminohydroxybutyric acid Drugs 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 229940062909 amyl salicylate Drugs 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 239000013040 bath agent Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 1
- 229950004580 benzyl nicotinate Drugs 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 229910002091 carbon monoxide Inorganic materials 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229960004504 chlorhexidine hydrochloride Drugs 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000019258 dehydroacetic acid Nutrition 0.000 description 1
- 229940061632 dehydroacetic acid Drugs 0.000 description 1
- JEQRBTDTEKWZBW-UHFFFAOYSA-N dehydroacetic acid Chemical compound CC(=O)C1=C(O)OC(C)=CC1=O JEQRBTDTEKWZBW-UHFFFAOYSA-N 0.000 description 1
- PGRHXDWITVMQBC-UHFFFAOYSA-N dehydroacetic acid Natural products CC(=O)C1C(=O)OC(C)=CC1=O PGRHXDWITVMQBC-UHFFFAOYSA-N 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 229960003887 dichlorophen Drugs 0.000 description 1
- 229940084113 diisopropylamine dichloroacetate Drugs 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- MCPKSFINULVDNX-UHFFFAOYSA-N drometrizole Chemical compound CC1=CC=C(O)C(N2N=C3C=CC=CC3=N2)=C1 MCPKSFINULVDNX-UHFFFAOYSA-N 0.000 description 1
- 229960002852 ellagic acid Drugs 0.000 description 1
- 235000004132 ellagic acid Nutrition 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 229960004756 ethanol Drugs 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- HPMLGOFBKNGJAM-ONEGZZNKSA-N ethyl (e)-3-(1h-imidazol-5-yl)prop-2-enoate Chemical compound CCOC(=O)\C=C\C1=CN=CN1 HPMLGOFBKNGJAM-ONEGZZNKSA-N 0.000 description 1
- NYNCZOLNVTXTTP-UHFFFAOYSA-N ethyl 2-(1,3-dioxoisoindol-2-yl)acetate Chemical compound C1=CC=C2C(=O)N(CC(=O)OCC)C(=O)C2=C1 NYNCZOLNVTXTTP-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000000417 fungicide Substances 0.000 description 1
- YQGDEPYYFWUPGO-UHFFFAOYSA-N gamma-amino-beta-hydroxybutyric acid Chemical compound [NH3+]CC(O)CC([O-])=O YQGDEPYYFWUPGO-UHFFFAOYSA-N 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
- 229960004068 hexachlorophene Drugs 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-N hexanoic acid Chemical compound CCCCCC(O)=O FUZZWVXGSFPDMH-UHFFFAOYSA-N 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 229920003063 hydroxymethyl cellulose Polymers 0.000 description 1
- 229940031574 hydroxymethyl cellulose Drugs 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 1
- SZVJSHCCFOBDDC-UHFFFAOYSA-N iron(II,III) oxide Inorganic materials O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 201000001441 melanoma Diseases 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229940117841 methacrylic acid copolymer Drugs 0.000 description 1
- 229920003145 methacrylic acid copolymer Polymers 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 229940017219 methyl propionate Drugs 0.000 description 1
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 1
- 239000011812 mixed powder Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- WIBFFTLQMKKBLZ-SEYXRHQNSA-N n-butyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCCC WIBFFTLQMKKBLZ-SEYXRHQNSA-N 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 231100000905 neutral red uptake (NRU) test Toxicity 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- VIKVSUVYUVJHOA-UHFFFAOYSA-N octyl 3-phenylprop-2-enoate Chemical compound CCCCCCCCOC(=O)C=CC1=CC=CC=C1 VIKVSUVYUVJHOA-UHFFFAOYSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 1
- 235000019809 paraffin wax Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229960000292 pectin Drugs 0.000 description 1
- 229940083256 peripheral vasodilators nicotinic acid and derivative Drugs 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229920000768 polyamine Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000010232 propyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004405 propyl p-hydroxybenzoate Substances 0.000 description 1
- 229960003415 propylparaben Drugs 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000008347 soybean phospholipid Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 229950009883 tocopheryl nicotinate Drugs 0.000 description 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- 239000006097 ultraviolet radiation absorber Substances 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- 229910001928 zirconium oxide Inorganic materials 0.000 description 1
Images
Landscapes
- Cosmetics (AREA)
Description
【0001】
【発明の属する技術分野】
本発明は、皮膚に対してすぐれた美白・美肌化作用を示し、基礎化粧料をはじめ、メイクアップ化粧料、浴用剤などとして有用な化粧料に関する。
【0002】
【従来の技術】
日焼け或いは加齢に伴って生ずる色素沈着、特にシミ、ソバカスを予防或いは症状改善し、皮膚を美麗かつ健常な状態に保持することを目的として、従来より種々の美白剤が提案され、それらを配合した化粧料が上市されている。しかしながら、それら従来の美白剤によっては、美白・美肌化効果と皮膚安全性の双方を十分満足せしめることは困難であり、かかる点の改善された美白剤を有効成分として含む新規な化粧料が求められている。
【0003】
【発明が解決しようとする課題】
本発明者らは、かかる従来技術の問題点に鑑み、皮膚安全性の観点から天然物由来の新たな美白有効成分を見出すべく鋭意研究を行った結果、後記特定の植物の抽出物が顕著なチロシナーゼ活性抑制作用を示し、これによって美白・美肌化効果と皮膚安全性にすぐれた化粧料の提供が可能となることを見出し、本発明を完成した。
【0004】
【課題を解決するための手段】
即ち、本発明は、以下の(a)(b)によって特徴付けられる抽出物を配合したことを特徴とする化粧料。
(a)タコノキ科タコノキ属に属する植物の抽出物
(b)美白作用及び美肌化作用を有する
【0005】
以下、本発明について詳細に説明する。
本発明で用いるタコノキ科タコノキ属の植物としては、例えばパンダヌス・アマリリフォリウス(Pandanus amaryllifolius Roxb.)、パンダヌス・アンダマネンジウム(P. andamanensium Kurz.)、パンダヌス・ボニネンシス(P. boninensis Weber.)、パンダヌス・コノイデア(P. conoidea Lamck.)、パンダヌス・エデュリス(P. edulis Thouars.)、パンダヌス・カフー(P. kafu Mart.)、パンダヌス・オードラス(P. odorus Ridl.)、パンダヌス・テクトリウス(P. tectorius Soland.)、パンダヌス・アティリス(P. utilis Bory.)などが挙げられる。それらのうちでも、有効性の観点からパンダヌス・アマリリフォリウスの使用が特に好ましい。
【0006】
それらのタコノキ属植物の抽出物の調製は、全草、葉、茎、根、種子など植物体の適宜の部分、好ましくは葉を用い、一般にはこれを予め水洗、乾燥、細切した上、抽出溶媒中に浸漬すること等によって行われる。
ここで抽出溶媒としては、水;メタノール、エタノール、プロパノールなどの低級アルコール類;エチレングリコール、プロピレングリコール、1、3−ブチレングリコール、グリセリンなどの多価アルコール類;酢酸エチル、酢酸ブチル、プロピオン酸メチルなどのエステル類;アセトン、メチルエチルケトンなどのケトン類;エチルエーテル、イソプロピルエーテルなどのエーテル類;n−ヘキサン、トルエン、クロロホルムなどの炭化水素系溶媒などがあり、それらのうちでも特に水又は水と低級アルコール類との混液もしくは水と多価アルコール類との混液の使用が好ましい。
【0007】
抽出温度、時間は、用いた植物の種類、細切度、抽出溶媒の種類等によっても異なるが、一般には5〜80℃で2時間〜7日間、特に20〜40℃で6〜48時間抽出を行うのがよい。ここに得られる抽出物溶液は、通常pHを4〜8に調整した上、そのままもしくは減圧濃縮等により適宜の濃度として使用される。また場合によっては、スプレードライ法、凍結乾燥法など常法に従って粉末化して使用してもよい。
【0008】
本発明の化粧料中に於ける上記の抽出物の配合量は、固形分濃度として、クリーム、乳液、ローションなどの基礎化粧料の場合であれば、一般に0.001〜0.5重量%、好ましくは0.01〜0.1重量%の範囲、またほほ紅、白粉などのメイクアップ化粧料の場合であれば、一般に0.001〜0.5重量%、好ましくは0.01〜0.1重量%の範囲であり、浴用剤の場合であれば、一般に0.01〜5重量%、好ましくは0.1〜1重量%の範囲である。
【0009】
本発明の化粧料には、必須成分のタコノキ属植物抽出物のほかに、通常化粧料に用いられる成分、例えば油性成分、界面活性剤、保湿剤、増粘剤、防腐・殺菌剤、粉体成分、紫外線吸収剤、抗酸化剤、色素、香料等が必要に応じて適宜配合される。
【0010】
ここで、油性成分としては、例えばオリーブ油、ホホバ油、ヒマシ油、大豆油、ヤシ油、パーム油、カカオ油、メドウホーム油などの植物由来の油脂類;ミンク油、タートル油などの動物由来の油脂類;ミツロウ、カルナウバロウ、ラノリンなどのロウ類;流動パラフィン、ワセリン、パラフィンワックス、スクワランなどの炭化水素類;ミリスチン酸、パルミチン酸、ステアリン酸、オレイン酸、イソステアリン酸などの脂肪酸類;ラウリルアルコール、セタノール、ステアリルアルコールなどの高級アルコール類;ミリスチン酸イソプロピル、オレイン酸ブチル、2−エチルヘキシルグリセライドなどの合成エステル類及び合成トリグリセライド類等が挙げられる。
【0011】
界面活性剤としては、例えばポリオキシエチレンアルキルエーテル、ポリオキシエチレン脂肪酸エステル、ポリオキシエチレンソルビタン脂肪酸エステル、グリセリン脂肪酸エステル、ポリグリセリン脂肪酸エステル、ポリオキシエチレングリセリン脂肪酸エステル、ポリオキシエチレン硬化ヒマシ油、ポリオキシエチレンソルビトール脂肪酸エステルなどの非イオン界面活性剤;脂肪酸塩、アルキル硫酸塩、アルキルベンゼンスルホン酸塩、ポリオキシエチレンアルキルエーテル硫酸塩、ポリオキシエチレン脂肪アミン硫酸塩、ポリオキシエチレンアルキルフェニルエーテル硫酸塩、ポリオキシエチレンアルキルエーテル燐酸塩、α−スルホン化脂肪酸アルキルエステル塩、ポリオキシエチレンアルキルフェニルエーテル燐酸塩などのアニオン界面活性剤;第四級アンモニウム塩、第一級〜第三級脂肪アミン塩、トリアルキルベンジルアンモニウム塩、アルキルピリジニウム塩、2−アルキル−1−アルキル−1−ヒドロキシエチルイミダゾリニウム塩、N、N−ジアルキルモルフォルニウム塩、ポリエチレンポリアミン脂肪酸アミド塩などのカチオン界面活性剤;N、N−ジメチル−N−アルキル−N−カルボキシメチルアンモニオベタイン、N、N、N−トリアルキル−N−アルキレンアンモニオカルボキシベタイン、N−アシルアミドプロピル−N′、N′−ジメチル−N′−β−ヒドロキシプロピルアンモニオスルホベタインなどの両性界面活性剤等が挙げられる。
【0012】
保湿剤としては、例えばグリセリン、プロピレングリコール、ジプロピレングリコール、1、3−ブチレングリコール、ポリエチレングリコール、ソルビトール、キシリトール、ピロリドンカルボンナトリウム等があり、さらに糖類、ヒアルロン酸、乳酸、尿素、高級脂肪酸オクチルドデシル、各種アミノ酸及びそれらの誘導体が挙げられる。
【0013】
増粘剤としては、例えばカラギーナン、アルギン酸、ペクチン、ローカストビーンガムなどの多糖類;キサンタンガム、トラガカントガム、グアーガムなどのガム類;カルボキシメチルセルロース、ヒドロキシエチルセルロースなどのセルロース誘導体;ポリビニルアルコール、ポリビニルピロリドン、カルボキシビニルポリマー、アクリル酸・メタクリル酸共重合体などの合成高分子類;ヒアルロン酸及びその誘導体等が挙げられる。
【0014】
防腐殺菌剤としては、例えば尿素;パラオキシ安息香酸メチル、パラオキシ安息香酸エチル、パラオキシ安息香酸プロピル、パラオキシ安息香酸ブチルなどのパラオキシ安息香酸エステル類;フェノキシエタノール、ジクロロフェン、ヘキサクロロフェン、塩酸クロルヘキシジン、塩化ベンザルコニウム、サリチル酸、エタノール、ウンデシレン酸、フェノール類、ジャマール(イミダゾデイニールウレア)等がある。
【0015】
粉体成分としては、例えばセリサイト、酸化チタン、タルク、カオリン、ベントナイト、酸化亜鉛、炭酸マグネシウム、酸化マグネシウム、酸化ジルコニウム、硫酸バリウム、無水ケイ酸、雲母、ナイロンパウダー等がある。
【0016】
紫外線吸収剤としては、例えばパラアミノ安息香酸エチル、パラジメチルアミノ安息香酸エチルヘキシル、サリチル酸アミル及びその誘導体、パラメトキシ桂皮酸エチルヘキシル、桂皮酸オクチル、2、4−ジヒドロキシベンゾフェノン、2−ヒドロキシ−4−メトキシベンゾフェノン−5−スルホン酸塩、2−(2−ヒドロキシ−5−メチルフェニル)ベンゾトリアゾール、ウロカニン酸、ウロカニン酸エチル等がある。
【0017】
抗酸化剤としては、例えばブチルヒドロキシアニソール、ブチルヒドロキシトルエン、没食子酸プロピル、ビタミンE及びその誘導体等がある。
又、その他の成分として、レシチン類、シルク関連物質等を配合することもできる。
【0018】
本発明の化粧料には、本発明の組み合わせ成分の有効性を損なわない範囲で、さらに他の生理活性成分を配合してもよい。かかるものとしては、例えばコウジ酸及びその誘導体(例えば、コウジ酸モノブチレート、コウジ酸モノカプレート、コウジ酸モノパルミテート、コウジ酸ジブチレートなどのコウジ酸エステル類或いはコウジ酸エーテル類等)、アルブチン、アスコルビン酸及びその誘導体[例えば、L−アスコルビン酸−2−リン酸エステル塩、L−アスコルビン酸−2−硫酸エステル塩などのアスコルビン酸エステル塩類(塩はナトリウム塩、マグネシウム塩など);L−アスコルビン酸−2−グルコシド(2−O−α−D−グルコピラノシル−L−アスコルビン酸)、L−アスコルビン酸−5−グルコシド(5−O−α−D−グルコピラノシル−L−アスコルビン酸)などのアスコルビン酸配糖体類等]、エラグ酸、レゾルシノール誘導体(例えば、4−n−ブチルレゾルシノール、4−イソアミルレゾルシノール等)、ソウハクヒ抽出液、ユキノシタ抽出液、米糠抽出物、2、5−ジヒドロキシ安息香酸誘導体(例えば2、5−ジアセトキシ安息香酸等)などの美白成分;胎盤抽出物、コラーゲン、ニコチン酸及びその誘導体(例えばニコチン酸アミド、ニコチン酸ベンジル等)、ビタミンE及びその誘導体(例えばビタミンEニコチネート、ビタミンEリノレート等)、α−ヒドロキシ酸類(例えば乳酸、クエン酸、α−ヒドロキシオクタン酸等)、ジイソプロピルアミンジクロロアセテート、γ−アミノ−β−ヒドロキシ酪酸などの皮膚老化防止・肌荒れ改善成分;ゲンチアナエキスなどの生薬抽出エキス等がある。
【0019】
次に、製造例、実施例(処方例)及び試験例によって本発明をさらに具体的に説明するが、本発明はそれらに限定されるものではない。なお、以下に於いて、部はすべて重量部を、また%はすべて重量%を意味する。
【0020】
製造例1 タコノキ属植物抽出物溶液の調製(1)
パンダヌス・アマリリフォリウスの葉の乾燥物を約5mmに細切したもの50gを、精製水500gに浸漬し、十分攪拌した後室温に18時間静置した。次にこれをろ過し、褐色透明の抽出物溶液350mlを得た(固形分濃度:1.02%)。
【0021】
製造例2 タコノキ属植物抽出物溶液の調製(2)
製造例1に於いて、抽出溶媒として精製水の代わりに精製水/エタノール=80/20(V/V)の混液を用いるほかは製造例1と同様にして、褐色透明の抽出物溶液380mlを得た(固形分濃度:0.65%)。
【0022】
製造例3 タコノキ属植物抽出物溶液の調製(3)
製造例1に於いて、タコノキ属植物としてパンダヌス・アマリリフォリウスに代えてパンダヌス・テクトリウスを用いるほかは製造例1と同様にして、褐色透明の抽出物溶液350mlを得た(固形分濃度:1.00%)。
【0023】
製造例4 タコノキ属植物抽出物溶液の調製(4)
製造例1に於いて、タコノキ属植物としてパンダヌス・アマリリフォリウスに代えてパンダヌス・アンダマネンジウムを用いるほかは製造例1と同様にして、褐色透明の抽出物溶液360mlを得た(固形分濃度:0.95%)。
【0024】
製造例5 タコノキ属植物抽出物粉末の調製
製造例1と同様にして得られた抽出物溶液を35mlに濃縮した後凍結乾燥し、抽出物粉末3.5gを得た。
【0025】
実施例1 クリーム
[A成分] 部
流動パラフィン 5.0
ヘキサラン[(株)テクノーブル製トリオクタン酸グリセリル] 4.0
パラフィン 5.0
グリセリルモノステアレート 2.0
ポリオキシエチレン(20)ソルビタンモノステアレート 6.0
ブチルパラベン 0.1
[B成分]
製造例1の抽出物溶液 5.0
グリセリン 5.0
カルボキシメチルモノステアレート 0.1
メチルパラベン 0.1
モイストン・C[(株)テクノーブル製NMF成分] 1.0
精製水 全量が100部となる量
[C成分]
香料 適量
上記のA成分とB成分をそれぞれ80℃以上に加熱した後、攪拌混合した。これを50℃まで冷却した後、C成分を加えてさらに攪拌混合してクリームを調製した。
【0026】
実施例2 乳液
[A成分] 部
流動パラフィン 6.0
ヘキサラン 4.0
ホホバ油 1.0
ポリオキシエチレン(20)ソルビタンモノステアレート 2.0
大豆レシチン 1.5
メチルパラベン 0.15
エチルパラベン 0.03
[B成分]
製造例2の抽出物溶液 2.5
グリセリン 3.0
1、3−ブチレングリコール 2.0
カルボキシメチルセルロース 0.3
ヒアルロン酸ナトリウム 0.01
精製水 全量が100部となる量
[C成分]
香料 適量
上記のA成分とB成分をそれぞれ80℃以上に加熱した後、攪拌混合した。これを50℃まで冷却した後、C成分を加えてさらに攪拌混合して乳液を調製した。
【0027】
実施例3 ローション
[成分] 部
製造例3の抽出物溶液 5.0
エタノール 10.0
グリセリン 3.0
1、3−ブチレングリコール 2.0
メチルパラベン 0.2
クエン酸 0.1
クエン酸ナトリウム 0.3
カルボキシビニルポリマー 0.1
香料 適量
精製水 全量が100部となる量
上記の成分を混合してローションを調製した。
【0028】
実施例4 パック
[成分] 部
ポリビニルアルコール 15.0
ヒドロキシメチルセルロース 5.0
プロピレングリコール 5.0
エタノール 10.0
メチルパラベン 0.2
製造例4の抽出物溶液 5.0
香料 適量
精製水 全量が100部となる量
上記の成分を混合してパックを調製した。
【0029】
実施例5 プレスパウダー
[A成分] 部
ベンガラ 0.5
黄酸化鉄 1.5
黒酸化鉄 0.1
酸化チタン 10.0
ナイロンパウダー 4.0
セリサイト 全量が100部となる量
マイカ 23.0
タルク 25.0
製造例5の抽出物粉末 0.2
[B成分]
スクワラン 1.0
メチルポリシロキサン 4.0
プロピルパラベン 0.1
デヒドロ酢酸 0.1
流動パラフィン 2.0
香料 適量
上記のA成分とB成分をそれぞれ混合攪拌し混合した後、200メッシュのタイラーメッシュの篩にかけ、得られた混合粉末を金型に打型して均一なプレスパウダーを調製した。
【0030】
実施例6 浴剤
[成分] 部
製造例5の抽出物粉末 0.5
硫酸ナトリウム 47.0
炭酸水素ナトリウム 全量が100部となる量
香料 適量
上記の成分を混合攪拌して均一な浴剤を調製した。
【0031】
比較例 クリーム
実施例1に於いて、製造例1のタコノキ属植物抽出物溶液5.0部に代えて、コウジ酸1.0部を用いるほかは実施例1と同様にしてクリームを調製した。
【0032】
対照例 クリーム
実施例1に於いて、製造例1のタコノキ属植物抽出物溶液を用いないほかは実施例1と同様にしてクリームを調製した。
【0033】
試験例1 細胞内チロシナーゼ活性抑制作用
[試験方法]
培養B16マウスメラノーマ細胞を、96穴マイクロプレートに1×104個/穴播種し、10%仔牛血清(FBS)含有イーグル最少必須培地(MEM)中、37℃、5%CO2の条件下に1日間プレ培養した後、培養液を、製造例1の抽出物溶液を2.5又は5.0%の濃度となるように添加した10%FBS含有イーグルMEMで置換し、同条件で2日間培養した。
次に培養液を除去し、界面活性剤(TritonX−100)を添加した細胞処理液に、5mMのL−ドーパ又は0.2%のMTTを添加して37℃でチロシナーゼ反応を行った後、マイクロプレートリーダー(Model1450、バイオラッド社製)を用い、波長490nmでドーパ値を、又570−630nmでMTT値をそれぞれ測定した。
なお、比較のため、製造例1の抽出物溶液の代わりに、2mMのコウジ酸を添加した場合及び試料無添加の場合(ブランク)についても、同様の試験を行った。
【0034】
[結果]
上記の試験で得られたドーパ値を図1に、又MTT値を図2に示した。
図1及び図2の結果から、本発明のタコノキ属植物抽出物が、細胞活性の低下を伴うことなく、細胞内チロシナーゼ活性を有意に抑制することが判る。
【0035】
試験例2 色素沈着抑制試験
本発明のタコノキ属植物抽出物のin vivo美白作用を、モルモットを用いた色素沈着抑制試験により評価した。
[試験方法]
有色モルモット(雄、8週齢)の背部中央部のタテ60mm×ヨコ30mmの体毛を剃毛し、該部分を左右二つに区画した。この区画の一方に製造例1の抽出物溶液を精製水で希釈して濃度5.0%とした液(試料溶液)を、他方に対照として精製水を、それぞれ朝、夕各1回5mlずつ6日間塗布すると共に、該塗布部位に毎日1回朝の塗布直前に500mJ/cm2のUV−Bを照射し、6日目の夕方に照射部位の色素沈着の状態を目視により観察し、以下の基準により評価した。
【0036】
[色素沈着の評価基準]
− : 色素沈着を認めない
± : 軽微な色素沈着を認める
+ : 軽度な色素沈着を認める
2+ : 中程度の色素沈着を認める
3+ : 重度な色素沈着を認める
【0037】
[結果]
結果を表1に示す。
【表1】
【0038】
表1の結果から明らかな通り、本発明のタコノキ属植物抽出物は、紫外線暴露に基づく皮膚への色素沈着を顕著に抑止する効果を有する。
試験例3 皮膚刺激性評価試験
眼粘膜刺激性試験の代替法である培養ウサギ角膜細胞(SIRC)を用いたニュートラルレッド取り込み試験により、各種美白成分の皮膚刺激性を評価した。
【0039】
[試料]
(1)製造例5の抽出物粉末
(2)コウジ酸
(3)アルブチン
【0040】
[試験方法]
SIRCを96穴マイクロプレートに5000個/穴播種し、5%仔牛血清含有イーグル最少必須培地(MEM)で3日間培養した後、これに試料を0.2%の濃度となるように添加し、さらに2日間培養した。次に、SIRCを0.05%ニュートラルレッド(NR)含有イーグルMEM培地で3時間培養し、ここに得られたSRICについてNRの取り込み率を求め、その値から各試料の皮膚刺激性を評価した。
【0041】
[結果]
結果を表2に示す。
【表2】
【0042】
表2に示す通り、本発明のタコノキ属植物抽出物は、既存の美白剤に比べて皮膚に対する刺激性が少なく、安全性にすぐれた化粧料を提供することが可能である。
【0043】
試験例4 モニターテスト
実施例1、比較例及び対照例の各クリームについて、モニターテストにより皮膚色素沈着に対する抑制効果並びに皮膚刺激性を調べた。
[試験方法]
無作為に抽出した年齢18〜50歳の女性20名を被験者とし、各クリームを1日2回(朝、晩)、1ヵ月間左上腕部にそれぞれ塗布し、塗布部の色素沈着の状態及び皮膚の紅斑を目視で観察し、以下の評価基準に基づいて評価した。
【0044】
[評価基準]
(色素沈着)
A:なくなった
B:明らかに少なくなった
C:いくらか少なくなった
D:殆ど変化がなかった
E:かえって多くなった
(紅斑)
A:対照例と差がない
B:対照例と殆ど差がない
C:対照例に比べて多少紅斑が目立つ
D:対照例に比べて相当紅斑が目立つ
E:対照例に比べて明らかに紅斑が目立つ
【0045】
[結果]
結果を表3に示す。
【0046】
【表3】
【0047】
表3に示す通り、本発明のタコノキ属植物抽出物を配合したクリームは、すぐれた色素沈着防止効果を具え、しかも皮膚に対する刺激が少なく安全性が高い。
【0048】
【発明の効果】
タコノキ科タコノキ属に属する植物の抽出物を配合してなる本発明の化粧料は、有効成分の上記抽出物の有する強いチロシナーゼ活性抑制作用により、シミ、ソバカスなど皮膚の色素沈着を顕著に抑制或は軽減すると共に、該抽出物が天然物由来のものであるため皮膚に対する刺激が少なく安全性にすぐれている。
【図面の簡単な説明】
【図1】図1は、試験例1の各試料のドーパ値を示すグラフである(縦軸:ドーパ値)。
【図2】図2は、試験例1の各試料のMTT値を示すグラフである(縦軸:MTT値)。[0001]
BACKGROUND OF THE INVENTION
The present invention relates to cosmetics that exhibit excellent whitening and skin-beautifying action on skin and are useful as basic cosmetics, makeup cosmetics, bath preparations and the like.
[0002]
[Prior art]
Various whitening agents have been proposed and formulated for the purpose of preventing or ameliorating pigmentation caused by sunburn or aging, especially spots and freckles, and maintaining the skin in a beautiful and healthy state. Cosmetics that have been put on the market. However, with these conventional whitening agents, it is difficult to sufficiently satisfy both the whitening and skin-beautifying effects and the skin safety, and there is a need for new cosmetics containing the whitening agent with improved such points as an active ingredient. It has been.
[0003]
[Problems to be solved by the invention]
In light of the problems of the prior art, the present inventors have conducted intensive research to find a new whitening active ingredient derived from a natural product from the viewpoint of skin safety. As a result, extracts of specific plants described below are remarkable. The present inventors have found that a tyrosinase activity-inhibiting action can be provided, and that this makes it possible to provide cosmetics with excellent whitening / skin-beautifying effects and skin safety, thereby completing the present invention.
[0004]
[Means for Solving the Problems]
That is, the present invention is a cosmetic comprising the extract characterized by the following (a) and (b) .
(A) An extract of a plant belonging to the genus Taconokiaceae
(B) It has a whitening effect and a skin beautifying effect.
Hereinafter, the present invention will be described in detail.
Examples of the plant belonging to the genus Taconokiaceae used in the present invention include Pandanus amaryllifolius Roxb., Panda andamanensium Kurz., Panda boninensis Weber. P. conoidea Lamck., P. edulis Thouars., P. kafu Mart., P. odorus Ridl., Panda tectorius (P. tectorius Soland.) and Panda utilis Bory. Among them, the use of Pandanus amaryllis is particularly preferable from the viewpoint of effectiveness.
[0006]
Preparation of the extracts of the genus Taconoki plant, using an appropriate part of the plant body, such as whole grass, leaves, stems, roots, seeds, preferably leaves, generally washed in advance, dried, shredded, It is carried out by immersing in an extraction solvent.
Here, the extraction solvent is water; lower alcohols such as methanol, ethanol and propanol; polyhydric alcohols such as ethylene glycol, propylene glycol, 1,3-butylene glycol and glycerine; ethyl acetate, butyl acetate and methyl propionate. Esters such as acetone; ketones such as acetone and methyl ethyl ketone; ethers such as ethyl ether and isopropyl ether; hydrocarbon solvents such as n-hexane, toluene and chloroform, among which water or water and lower It is preferable to use a mixed solution of alcohols or a mixed solution of water and polyhydric alcohols.
[0007]
Although the extraction temperature and time vary depending on the type of plant used, the degree of shredding, the type of extraction solvent, etc., it is generally extracted at 5 to 80 ° C. for 2 hours to 7 days, particularly at 20 to 40 ° C. for 6 to 48 hours. It is good to do. The extract solution obtained here is usually used as an appropriate concentration by adjusting the pH to 4-8, as it is or by concentration under reduced pressure. In some cases, it may be used after being powdered according to a conventional method such as spray drying or freeze drying.
[0008]
The amount of the above extract in the cosmetic of the present invention is generally 0.001 to 0.5% by weight, preferably 0.01 to 0.5% in the case of basic cosmetics such as creams, milky lotions and lotions as the solid content concentration. In the case of makeup cosmetics such as blusher and white powder, it is generally in the range of 0.001 to 0.5% by weight, preferably 0.01 to 0.1% by weight, and in the case of a bath preparation, In general, it is in the range of 0.01 to 5% by weight, preferably 0.1 to 1% by weight.
[0009]
The cosmetics of the present invention include components that are usually used in cosmetics, such as oily ingredients, surfactants, moisturizers, thickeners, antiseptic / disinfectants, powders, in addition to the essential components of the genus Taconoki plant extract. Components, ultraviolet absorbers, antioxidants, pigments, fragrances, and the like are appropriately blended as necessary.
[0010]
Here, as the oily component, for example, oils derived from plants such as olive oil, jojoba oil, castor oil, soybean oil, coconut oil, palm oil, cacao oil, and meadowweed oil; derived from animals such as mink oil and turtle oil Fats and oils; waxes such as beeswax, carnauba wax and lanolin; hydrocarbons such as liquid paraffin, petrolatum, paraffin wax and squalane; fatty acids such as myristic acid, palmitic acid, stearic acid, oleic acid and isostearic acid; lauryl alcohol; Examples include higher alcohols such as cetanol and stearyl alcohol; synthetic esters such as isopropyl myristate, butyl oleate, and 2-ethylhexyl glyceride, and synthetic triglycerides.
[0011]
Examples of the surfactant include polyoxyethylene alkyl ether, polyoxyethylene fatty acid ester, polyoxyethylene sorbitan fatty acid ester, glycerin fatty acid ester, polyglycerin fatty acid ester, polyoxyethylene glycerin fatty acid ester, polyoxyethylene hydrogenated castor oil, polyoxyethylene Nonionic surfactants such as oxyethylene sorbitol fatty acid esters; fatty acid salts, alkyl sulfates, alkylbenzene sulfonates, polyoxyethylene alkyl ether sulfates, polyoxyethylene fatty amine sulfates, polyoxyethylene alkyl phenyl ether sulfates, Polyoxyethylene alkyl ether phosphates, α-sulfonated fatty acid alkyl ester salts, polyoxyethylene alkyl phenyl ether phosphates, Quaternary ammonium salt, primary to tertiary fatty amine salt, trialkylbenzylammonium salt, alkylpyridinium salt, 2-alkyl-1-alkyl-1-hydroxyethylimidazolinium salt, N Cationic surfactants such as N, N-dialkylmorphonium salt, polyethylene polyamine fatty acid amide salt; N, N-dimethyl-N-alkyl-N-carboxymethylammoniobetaine, N, N, N-trialkyl-N- Examples include amphoteric surfactants such as alkylene ammoniocarboxybetaine, N-acylamidopropyl-N ′, and N′-dimethyl-N′-β-hydroxypropylammoniosulfobetaine.
[0012]
Examples of the humectant include glycerin, propylene glycol, dipropylene glycol, 1,3-butylene glycol, polyethylene glycol, sorbitol, xylitol, pyrrolidone carboxyl sodium and the like, and sugars, hyaluronic acid, lactic acid, urea, higher fatty acid octyldodecyl. And various amino acids and derivatives thereof.
[0013]
Examples of the thickener include polysaccharides such as carrageenan, alginic acid, pectin and locust bean gum; gums such as xanthan gum, tragacanth gum and guar gum; cellulose derivatives such as carboxymethylcellulose and hydroxyethylcellulose; polyvinyl alcohol, polyvinylpyrrolidone and carboxyvinyl polymer And synthetic polymers such as acrylic acid / methacrylic acid copolymer; hyaluronic acid and derivatives thereof.
[0014]
Examples of antiseptic fungicides include urea; paraoxybenzoates such as methyl paraoxybenzoate, ethyl paraoxybenzoate, propyl paraoxybenzoate, and butyl paraoxybenzoate; phenoxyethanol, dichlorophene, hexachlorophene, chlorhexidine hydrochloride, benzalkco chloride Examples include nium, salicylic acid, ethanol, undecylenic acid, phenols, and jamal (imidazodenyl urea).
[0015]
Examples of the powder component include sericite, titanium oxide, talc, kaolin, bentonite, zinc oxide, magnesium carbonate, magnesium oxide, zirconium oxide, barium sulfate, silicic anhydride, mica, and nylon powder.
[0016]
Examples of the ultraviolet absorber include ethyl paraaminobenzoate, ethylhexyl paradimethylaminobenzoate, amyl salicylate and derivatives thereof, ethylhexyl paramethoxycinnamate, octyl cinnamate, 2,4-dihydroxybenzophenone, 2-hydroxy-4-methoxybenzophenone- 5-sulfonate, 2- (2-hydroxy-5-methylphenyl) benzotriazole, urocanic acid, ethyl urocanate and the like.
[0017]
Examples of the antioxidant include butylhydroxyanisole, butylhydroxytoluene, propyl gallate, vitamin E and derivatives thereof.
In addition, lecithins, silk-related substances and the like can be blended as other components.
[0018]
The cosmetic of the present invention may further contain other physiologically active ingredients as long as the effectiveness of the combination component of the present invention is not impaired. Examples of such compounds include kojic acid and derivatives thereof (for example, kojic acid esters such as kojic acid monobutyrate, kojic acid monocaprate, kojic acid monopalmitate, kojic acid dibutyrate or kojic acid ethers), arbutin, ascorbine, etc. Acids and derivatives thereof [for example, ascorbic acid esters such as L-ascorbic acid-2-phosphate and L-ascorbic acid-2-sulfate (salts are sodium salt, magnesium salt, etc.); L-ascorbic acid Ascorbic acid coordination such as 2-glucoside (2-O-α-D-glucopyranosyl-L-ascorbic acid), L-ascorbic acid-5-glucoside (5-O-α-D-glucopyranosyl-L-ascorbic acid) Sugars, etc.], ellagic acid, resorcinol derivatives (for example, 4 Whitening ingredients such as n-butylresorcinol, 4-isoamylresorcinol), Sakuhachi extract, yukinoshita extract, rice bran extract, 2,5-dihydroxybenzoic acid derivatives (eg 2,5-diacetoxybenzoic acid, etc.); Extract, collagen, nicotinic acid and derivatives thereof (eg nicotinamide, benzyl nicotinate, etc.), vitamin E and derivatives thereof (eg vitamin E nicotinate, vitamin E linoleate, etc.), α-hydroxy acids (eg lactic acid, citric acid, α-hydroxyoctanoic acid and the like), diisopropylamine dichloroacetate, γ-amino-β-hydroxybutyric acid and other skin aging prevention / rough skin improving components; herbal medicine extract such as gentian extract.
[0019]
Next, the present invention will be described more specifically with reference to production examples, examples (formulation examples), and test examples, but the present invention is not limited thereto. In the following, all parts are by weight, and all% are by weight.
[0020]
Production Example 1 Preparation of an extract solution of the genus Octopus (1)
50 g of a dried product of Pandanus amaririforius leaves cut into about 5 mm was immersed in 500 g of purified water, sufficiently stirred, and then allowed to stand at room temperature for 18 hours. Next, this was filtered to obtain 350 ml of a brown transparent extract solution (solid content concentration: 1.02%).
[0021]
Production Example 2 Preparation of an extract solution of the genus Octopus (2)
In Production Example 1, 380 ml of a brown transparent extract solution was prepared in the same manner as in Production Example 1 except that a mixed liquid of purified water / ethanol = 80/20 (V / V) was used instead of purified water as an extraction solvent. Obtained (solid content concentration: 0.65%).
[0022]
Production Example 3 Preparation of an extract of the genus Octopus (3)
In Production Example 1, 350 ml of a brown transparent extract solution was obtained in the same manner as in Production Example 1 except that Pandanus tectorius was used in place of Pandanus amaryrifolios as the genus Taconoki. 0.00%).
[0023]
Production Example 4 Preparation of an extract of the genus Octopus (4)
In Production Example 1, a transparent brown extract solution (360 ml) was obtained in the same manner as in Production Example 1 except that Pandanus adamiliforius was used instead of Pandanus amaririfolios as the genus Taconoki. : 0.95%).
[0024]
Production Example 5 Preparation of Octopus Plant Extract Powder The extract solution obtained in the same manner as in Production Example 1 was concentrated to 35 ml and freeze-dried to obtain 3.5 g of extract powder.
[0025]
Example 1 Cream [component A] Partial liquid paraffin 5.0
Hexalan [Glyceryl trioctanoate manufactured by Technoble Co., Ltd.] 4.0
Paraffin 5.0
Glyceryl monostearate 2.0
Polyoxyethylene (20) sorbitan monostearate 6.0
Butylparaben 0.1
[B component]
Extract solution of Production Example 1 5.0
Glycerin 5.0
Carboxymethyl monostearate 0.1
Methylparaben 0.1
Moiston C [NMF component manufactured by Technoble Co., Ltd.] 1.0
Purified water Amount of 100 parts [component C]
Fragrance Appropriate amount Each of the above components A and B was heated to 80 ° C. or higher, and then mixed by stirring. After cooling this to 50 degreeC, C component was added, and also it stirred and mixed and prepared the cream.
[0026]
Example 2 Latex [Component A] Partial liquid paraffin 6.0
Hexalan 4.0
Jojoba oil 1.0
Polyoxyethylene (20) sorbitan monostearate 2.0
Soy lecithin 1.5
Methylparaben 0.15
Ethylparaben 0.03
[B component]
Extract solution of Production Example 2 2.5
Glycerin 3.0
1,3-butylene glycol 2.0
Carboxymethylcellulose 0.3
Sodium hyaluronate 0.01
Purified water Amount of 100 parts [component C]
Fragrance Appropriate amount Each of the above components A and B was heated to 80 ° C. or higher, and then mixed by stirring. After cooling this to 50 ° C., component C was added and further stirred and mixed to prepare an emulsion.
[0027]
Example 3 Lotion [Ingredient] Part Extract Example 3 Extract Solution 5.0
Ethanol 10.0
Glycerin 3.0
1,3-butylene glycol 2.0
Methylparaben 0.2
Citric acid 0.1
Sodium citrate 0.3
Carboxyvinyl polymer 0.1
Fragrance Appropriate amount of purified water An amount that makes the total amount 100 parts.
[0028]
Example 4 Pack [component] part polyvinyl alcohol 15.0
Hydroxymethylcellulose 5.0
Propylene glycol 5.0
Ethanol 10.0
Methylparaben 0.2
Extract solution of Production Example 4 5.0
Fragrance Appropriate amount of purified water An amount that makes the total amount 100 parts. The above ingredients were mixed to prepare a pack.
[0029]
Example 5 Press powder [component A] Part Bengala 0.5
Yellow iron oxide 1.5
Black iron oxide 0.1
Titanium oxide 10.0
Nylon powder 4.0
Amount of mica that makes 100 parts of sericite 23.0
Talc 25.0
Extract powder of production example 5 0.2
[B component]
Squalane 1.0
Methylpolysiloxane 4.0
Propylparaben 0.1
Dehydroacetic acid 0.1
Liquid paraffin 2.0
Fragrance Appropriate Amounts The above A component and B component were mixed and stirred, mixed, then passed through a 200 mesh Tyler mesh sieve, and the resulting mixed powder was cast into a mold to prepare a uniform press powder.
[0030]
Example 6 Bath agent [ingredient] Part extract powder of Production Example 5 0.5
Sodium sulfate 47.0
Sodium bicarbonate Amount of fragrance in which the total amount becomes 100 parts An appropriate amount The above ingredients were mixed and stirred to prepare a uniform bath preparation.
[0031]
Comparative Example A cream was prepared in the same manner as in Example 1 except that 1.0 part of kojic acid was used instead of 5.0 parts of the plant extract solution of Production Example 1 in Cream Example 1.
[0032]
Control Example A cream was prepared in the same manner as in Example 1 except that in Example 1, the extract of the plant of the genus Taconoki of Production Example 1 was not used.
[0033]
Test Example 1 Inhibitory action on intracellular tyrosinase activity [Test method]
Cultured B16 mouse melanoma cells were seeded at 1 × 10 4 cells / well in a 96-well microplate, and in a minimal essential medium (MEM) containing 10% calf serum (FBS) at 37 ° C. and 5% CO 2 for 1 day. After pre-culture, the culture solution was replaced with Eagle MEM containing 10% FBS to which the extract solution of Production Example 1 was added to a concentration of 2.5 or 5.0%, and cultured under the same conditions for 2 days. .
Next, after removing the culture solution and adding a 5 mM L-dopa or 0.2% MTT to the cell treatment solution to which the surfactant (TritonX-100) was added, a tyrosinase reaction was performed at 37 ° C. Using a microplate reader (Model 1450, manufactured by Bio-Rad), the dopa value was measured at a wavelength of 490 nm, and the MTT value was measured at 570-630 nm.
For comparison, the same test was performed for the case where 2 mM kojic acid was added instead of the extract solution of Production Example 1 and when no sample was added (blank).
[0034]
[result]
The dopa values obtained in the above test are shown in FIG. 1, and the MTT values are shown in FIG.
From the results of FIG. 1 and FIG. 2, it can be seen that the plant extract of the genus Taconium of the present invention significantly suppresses the intracellular tyrosinase activity without being accompanied by a decrease in the cell activity.
[0035]
Test Example 2 Pigmentation Inhibition Test The in vivo whitening action of the extract of the genus Taconoki of the present invention was evaluated by a pigmentation inhibition test using guinea pigs.
[Test method]
The body hair of length 60 mm × width 30 mm in the center of the back of a colored guinea pig (male, 8 weeks old) was shaved, and the part was divided into two on the left and right. In one of the compartments, a solution (sample solution) having a concentration of 5.0% obtained by diluting the extract solution of Production Example 1 with purified water, and purified water as a control in the other, 5 ml each time in the morning and evening. It was applied for 6 days, and the application site was irradiated with UV-B of 500 mJ / cm 2 once a day immediately in the morning, and the pigmentation state of the irradiation site was visually observed in the evening of the sixth day. Evaluation was made according to the criteria.
[0036]
[Evaluation criteria for pigmentation]
−: No pigmentation is observed ±: Slight pigmentation is observed +: Mild pigmentation is observed 2+: Moderate pigmentation is observed 3+: Severe pigmentation is observed [0037]
[result]
The results are shown in Table 1.
[Table 1]
[0038]
As is apparent from the results of Table 1, the plant extract of the genus Taconium of the present invention has an effect of remarkably suppressing the pigmentation on the skin based on exposure to ultraviolet rays.
Test Example 3 Skin irritation evaluation test Skin irritation of various whitening components was evaluated by a neutral red uptake test using cultured rabbit corneal cells (SIRC), which is an alternative method to the eye mucosa irritation test.
[0039]
[sample]
(1) Extract powder of Production Example 5 (2) Kojic acid (3) Arbutin
[Test method]
SIRC was seeded at 5000 cells / well in a 96-well microplate, cultured in Eagle's minimum essential medium (MEM) containing 5% calf serum for 3 days, and then the sample was added to a concentration of 0.2%. The culture was further continued for 2 days. Next, SIRC was cultured in Eagle MEM medium containing 0.05% neutral red (NR) for 3 hours, and the NR uptake rate was determined for the SRIC obtained here, and the skin irritation of each sample was evaluated from the value. .
[0041]
[result]
The results are shown in Table 2.
[Table 2]
[0042]
As shown in Table 2, the Taconoki plant extract of the present invention is less irritating to the skin than existing whitening agents, and can provide a cosmetic with excellent safety.
[0043]
Test Example 4 Monitor Test For each cream of Example 1, Comparative Example and Control Example, the inhibitory effect on skin pigmentation and skin irritation were examined by monitor test.
[Test method]
Twenty randomly selected women aged 18 to 50 years were used as subjects, and each cream was applied to the left upper arm twice a day (morning and evening) for 1 month. The erythema of the skin was visually observed and evaluated based on the following evaluation criteria.
[0044]
[Evaluation criteria]
(Pigmentation)
A: Lost B: Clearly decreased C: Somewhat decreased D: Almost unchanged E: On the contrary increased (erythema)
A: No difference from the control
B: Little difference from the control example C: Some erythema is more noticeable than the control example D: Equivalent erythema is noticeable compared to the control example E: Erythema is clearly noticeable compared to the control example
[result]
The results are shown in Table 3.
[0046]
[Table 3]
[0047]
As shown in Table 3, the cream containing the extract of the genus Taconoki of the present invention has an excellent anti-pigmentation effect and is highly safe with little irritation to the skin.
[0048]
【The invention's effect】
The cosmetic composition of the present invention, which is formulated with an extract of a plant belonging to the genus Taconokiaceae, remarkably suppresses skin pigmentation such as stains and buckwheat by virtue of the strong tyrosinase activity inhibitory action of the above-mentioned extract as an active ingredient. Is reduced, and since the extract is derived from a natural product, there is little irritation to the skin and it is excellent in safety.
[Brief description of the drawings]
FIG. 1 is a graph showing the dopa value of each sample of Test Example 1 (vertical axis: dopa value).
FIG. 2 is a graph showing the MTT value of each sample of Test Example 1 (vertical axis: MTT value).
Claims (2)
(a)タコノキ科タコノキ属に属する植物の抽出物である
(b)美白作用及び美肌化作用を有する A cosmetic comprising an extract characterized by the following (a) and (b):
(A) An extract of a plant belonging to the genus Taconokiaceae
(B) Has a whitening effect and a skin beautifying effect
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000312429A JP4445658B2 (en) | 2000-10-12 | 2000-10-12 | Cosmetics |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2000312429A JP4445658B2 (en) | 2000-10-12 | 2000-10-12 | Cosmetics |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2002121110A JP2002121110A (en) | 2002-04-23 |
| JP4445658B2 true JP4445658B2 (en) | 2010-04-07 |
Family
ID=18792022
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2000312429A Expired - Fee Related JP4445658B2 (en) | 2000-10-12 | 2000-10-12 | Cosmetics |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP4445658B2 (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4378448A1 (en) | 2022-11-30 | 2024-06-05 | PBCLABS Sp. z o.o. | Extract of flowers, leaves and/or seed pods of impatiens and leaves of pandanus, in dried and liquid form, a method of its obtaining and use thereof |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6978015B1 (en) * | 2020-06-29 | 2021-12-08 | 徹 中西 | Composition for skin application to increase the expression of CCN1 and CCN2 |
| CN114403435B (en) * | 2022-01-25 | 2023-09-19 | 中国热带农业科学院橡胶研究所 | Preparation method and application of Banlan powder |
| CN115919722A (en) * | 2022-08-26 | 2023-04-07 | 广东芭薇生物科技股份有限公司 | A kind of extract of Pandanus leaves and its preparation method and application |
| CN117959228B (en) * | 2024-03-28 | 2024-06-11 | 威莱(广州)日用品有限公司 | Anti-dandruff and anti-hair-loss shampoo containing natural plant components and preparation method thereof |
-
2000
- 2000-10-12 JP JP2000312429A patent/JP4445658B2/en not_active Expired - Fee Related
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4378448A1 (en) | 2022-11-30 | 2024-06-05 | PBCLABS Sp. z o.o. | Extract of flowers, leaves and/or seed pods of impatiens and leaves of pandanus, in dried and liquid form, a method of its obtaining and use thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| JP2002121110A (en) | 2002-04-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US7700123B2 (en) | Cosmetics | |
| JP3576200B2 (en) | Whitening cosmetics | |
| JP4495925B2 (en) | Collagen and elastin production promoter and anti-aging cosmetic containing the same | |
| JP3601875B2 (en) | Cosmetics | |
| JP4592911B2 (en) | Cosmetics | |
| JP3987825B2 (en) | Cosmetics and cosmetic ingredients | |
| JP3846680B2 (en) | Cosmetics | |
| JP4445658B2 (en) | Cosmetics | |
| JP4424561B2 (en) | Whitening cosmetics | |
| JP2014221754A (en) | Cosmetic | |
| JP5177827B2 (en) | Topical skin preparation | |
| JP3987733B2 (en) | Fibroblast activator and skin external preparation containing the same | |
| JP2005145938A (en) | Active oxygen scavenger and cosmetic | |
| JP4621958B2 (en) | Cosmetic compounding agent and cosmetics containing the same | |
| JP5175411B2 (en) | Cosmetics | |
| JP5057638B2 (en) | Topical skin preparation | |
| JP3818998B2 (en) | Whitening cosmetics | |
| JP4500906B2 (en) | Cosmetic compounding agent and cosmetics containing the same | |
| JP2005126394A (en) | Superoxide dismutase activity enhancer and cosmetic containing the same | |
| JP2003012449A (en) | Cosmetics | |
| JPH0952817A (en) | Whitening cosmetics | |
| JPH09175980A (en) | Cosmetic | |
| JP2004262894A (en) | Skin/hair protecting agent and cosmetic containing the same | |
| JP5074163B2 (en) | Cosmetics | |
| JP2000351722A (en) | Skin cosmetic |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20071001 |
|
| A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20090819 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20090915 |
|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20091116 |
|
| TRDD | Decision of grant or rejection written | ||
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20091116 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20100105 |
|
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20100118 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130122 Year of fee payment: 3 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20160122 Year of fee payment: 6 |
|
| LAPS | Cancellation because of no payment of annual fees |